MX2018002786A - Composicion farmaceutica de vinpocetina. - Google Patents
Composicion farmaceutica de vinpocetina.Info
- Publication number
- MX2018002786A MX2018002786A MX2018002786A MX2018002786A MX2018002786A MX 2018002786 A MX2018002786 A MX 2018002786A MX 2018002786 A MX2018002786 A MX 2018002786A MX 2018002786 A MX2018002786 A MX 2018002786A MX 2018002786 A MX2018002786 A MX 2018002786A
- Authority
- MX
- Mexico
- Prior art keywords
- vinpocetine
- pharmaceutical composition
- epilepsy
- treatment
- present
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La presente invención está dirigida a una composición farmacéutica de liberación prolongada que comprende vinpocetina como principio activo. También se describe la farmacocinética de la composición farmacéutica. La composición divulgada se encuentra dirigida al tratamiento de enfermedades del sistema nervioso central como lo son la epilepsia y epilepsia refractaria.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2015/048295 WO2017039670A1 (en) | 2015-09-03 | 2015-09-03 | Vinpocetine pharmaceutical composition |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2018002786A true MX2018002786A (es) | 2018-12-17 |
Family
ID=58188718
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2018002786A MX2018002786A (es) | 2015-09-03 | 2015-09-03 | Composicion farmaceutica de vinpocetina. |
Country Status (2)
Country | Link |
---|---|
MX (1) | MX2018002786A (es) |
WO (1) | WO2017039670A1 (es) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4904476A (en) * | 1986-03-04 | 1990-02-27 | American Home Products Corporation | Formulations providing three distinct releases |
US20070135470A1 (en) * | 2003-10-28 | 2007-06-14 | Universidad Nacional Autonoma De Mexico | Utilization of vinpocetine to avoid complications in particular those associated to hearing which occur with epilepsy, and treatment thereof |
US20050096369A1 (en) * | 2003-11-04 | 2005-05-05 | Hoang Ba X. | Compositions and methods for treating cellular proliferation disorders |
WO2010002835A2 (en) * | 2008-07-03 | 2010-01-07 | Osteogenex, Inc. | Vinpocetine and eburnamonine derivatives for promoting bone growth |
-
2015
- 2015-09-03 MX MX2018002786A patent/MX2018002786A/es unknown
- 2015-09-03 WO PCT/US2015/048295 patent/WO2017039670A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2017039670A1 (en) | 2017-03-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12018500586A1 (en) | Farnesoid x receptor agonists and uses thereof | |
MX2021000071A (es) | Uso de pridopidina para mejorar la funcion cognitiva y para tratamiento de enfermedad de alzheimer. | |
NZ735000A (en) | Methods for the treatment of abnormal involuntary movement disorders | |
PH12017500401A1 (en) | Therapeutic compounds as inhibitors of the orexin-1 receptor | |
MX2017006437A (es) | Compuestos espiroisoquinolin-1,4'-piperidinicos con actividad multimodal contra el dolor. | |
MA39765A (fr) | Formulation pharmaceutique d'un inhibiteur de la kinase pan-raf, ses procédés de préparation, et procédés d'utilisation | |
MX2021010041A (es) | Composiciones farmaceuticas que comprenden inhibidores de la proteina quinasa akt. | |
MX2017014456A (es) | Usos terapeuticos de l-4-cloroquinurenina. | |
PH12016502233A1 (en) | (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine | |
EP3336100A4 (en) | PEPTIDE WITH EFFECT FOR PREVENTING OR TREATING DISEASES OF THE CENTRAL NERVOUS SYSTEM AND PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING DISEASES OF THE CENTRAL NERVOUS SYSTEM THEREFOR AS AN ACTIVE SUBSTANCE | |
MX2019001634A (es) | Compuestos amidas, composiciones farmacéuticas de estos y métodos para utilizarlos. | |
PH12018500814A1 (en) | Oxadiazaspiro compounds for the treatment of drug abuse and addiction | |
PH12016502236A1 (en) | (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine | |
MD20180049A2 (ro) | Compoziţie farmaceutică | |
PH12018500682A1 (en) | Oxa-diazaspiro compounds having activity against pain | |
MX2019004736A (es) | Mini-tabletas de melatonina y metodos de fabricacion de las mismas. | |
MX2018006631A (es) | Compuesto para uso en la prevencion y tratamiento de enfermedades neurodegenerativas. | |
MX2018004774A (es) | Derivados de morfolina sustituidos que tienen actividad contra el dolor. | |
MX2018002786A (es) | Composicion farmaceutica de vinpocetina. | |
MX2018000418A (es) | Derivados de amida que tienen actividad multimodal contra el dolor. | |
MX2018003564A (es) | 1,4-benzodiazepinas biheteroarilo sustituidas y usos de las mismas para el tratamiento del cancer. | |
MX2018004776A (es) | Compuestos oxaazaespiricos con actividad contral el dolor. | |
MX2019014773A (es) | Inhibidores de ccl2. | |
EA201692221A1 (ru) | Фармацевтическая композиция для профилактики и лечения заболеваний, связанных с повышенной активностью индуцируемой синтазы окиси азота | |
MX2014013240A (es) | Composicion farmaceutica para el tratamiento de la disfuncion erectil a base de un farmaco inhibidor de la enzima pde-5 (fosfodiesterasa tipo 5) en tabletas. |